Comunicati Stampa
Salute e Benessere

Biomarkers Market to Grow at 13.1% CAGR from 2024 to 2029

The report covers the market's size, growth trends, product types, technologies, therapeutic areas, and end-users. It includes instruments, consumables, services, software, and technologies such as genomics, proteomics, metabolomics, imaging, and bioinformatics. The report also examines therapeutic areas such as cancer and cardiovascular diseases and end users such as academic institutions and hospitals. It covers North America, Europe, Asia-Pacific, and the Rest of the World and profiles leading companies and industry trends.
BOSTON, (informazione.news - comunicati stampa - salute e benessere)

The report covers the market's size, growth trends, product types, technologies, therapeutic areas, and end-users. It includes instruments, consumables, services, software, and technologies such as genomics, proteomics, metabolomics, imaging, and bioinformatics. The report also examines therapeutic areas such as cancer and cardiovascular diseases and end users such as academic institutions and hospitals. It covers North America , Europe , Asia-Pacific , and the Rest of the World and profiles leading companies and industry trends.

This report is particularly relevant at the moment due to the growing demand for personalized medicine, which requires biomarkers to predict patient responses to treatments. It analyzes current trends in biomarker research and how they align with individualized patient care. Rapid genomics, proteomics, and metabolomics advances, driven by technologies such as next-generation sequencing, mass spectrometry, and machine learning, are revolutionizing biomarker identification and validation.

The growing prevalence of chronic and infectious diseases increases the need for biomarkers, which aid in early detection, diagnosis, and monitoring.

Omics (genomics, proteomics, metabolomics) and advanced imaging techniques have transformed biomarker research, enabled precise identification and analysis of biological markers, and enhanced our understanding of diseases.

Biomarkers are crucial in personalized medicine, helping to tailor treatments to individual patients based on their genetic and molecular profiles, resulting in more effective and targeted therapies with fewer side effects.

 

•         Demand for personalized medicine.

 

For further information or any of these reports or to make a purchase, please contact info@bccresearch.com.    

BCC Research market research reports provide objective, unbiased measurement, and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.

Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA
Email: info@bccresearch.com
Phone: +1 781-489-7301

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/biomarkers-market-to-grow-at-13-1-cagr-from-2024-to-2029--302441733.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili